RxDoctor Payments Data
★ My doctorsLook up a doctor →

Marian Chen Hah

Internal Medicine · Orange, TXNPI 1407963317

Payments from drug & device makers

$1,382in general payments, 2019–2025

Across 101 payments — averaging $13.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$321
  • AbbVie$184
  • Amarin Pharma, Inc.$150
  • AstraZeneca$139
  • Pfizer$105
  • Merck$91
  • plus $392 from 13 others

What the payments were for

  • Food & beverage$1,382100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk26$321
AbbVie(2 entities)18$184
Amarin Pharma, Inc.8$150
AstraZeneca10$139
Pfizer7$105
Merck6$91
Merz North America, Inc.4$79
Amgen4$50
Optinose US, Inc.3$39
Astellas Pharma US Inc2$35
Arbor Pharmaceuticals, Inc.2$31
Genentech USA, Inc.2$30
Daiichi Sankyo Inc.2$27
Esperion Therapeutics, Inc.2$26
Biohaven Pharmaceuticals, Inc.1$20
Aytu Biopharma, Inc.1$18
Teva Pharmaceuticals USA, Inc.1$13
Johnson & Johnson1$13
Eisai Inc.1$12

How this compares

$1,382 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Orange

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →